116 related articles for article (PubMed ID: 38890753)
1. Loss of protein tyrosine phosphatase receptor delta PTPRD increases the number of cortical neurons, impairs synaptic function and induces autistic-like behaviors in adult mice.
Cortés BI; Meza RC; Ancatén-González C; Ardiles NM; Aránguiz MI; Tomita H; Kaplan DR; Cornejo F; Nunez-Parra A; Moya PR; Chávez AE; Cancino GI
Biol Res; 2024 Jun; 57(1):40. PubMed ID: 38890753
[TBL] [Abstract][Full Text] [Related]
2. The Protein Tyrosine Phosphatase Receptor Delta Regulates Developmental Neurogenesis.
Tomita H; Cornejo F; Aranda-Pino B; Woodard CL; Rioseco CC; Neel BG; Alvarez AR; Kaplan DR; Miller FD; Cancino GI
Cell Rep; 2020 Jan; 30(1):215-228.e5. PubMed ID: 31914388
[TBL] [Abstract][Full Text] [Related]
3. IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase δ.
Yoshida T; Yasumura M; Uemura T; Lee SJ; Ra M; Taguchi R; Iwakura Y; Mishina M
J Neurosci; 2011 Sep; 31(38):13485-99. PubMed ID: 21940441
[TBL] [Abstract][Full Text] [Related]
4. Neural conditional ablation of the protein tyrosine phosphatase receptor Delta PTPRD impairs gliogenesis in the developing mouse brain cortex.
Cornejo F; Franchini N; Cortés BI; Elgueta D; Cancino GI
Front Cell Dev Biol; 2024; 12():1357862. PubMed ID: 38487272
[TBL] [Abstract][Full Text] [Related]
5. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.
Ortiz B; Fabius AW; Wu WH; Pedraza A; Brennan CW; Schultz N; Pitter KL; Bromberg JF; Huse JT; Holland EC; Chan TA
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8149-54. PubMed ID: 24843164
[TBL] [Abstract][Full Text] [Related]
6. Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.
Uhl GR; Martinez MJ; Paik P; Sulima A; Bi GH; Iyer MR; Gardner E; Rice KC; Xi ZX
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11597-11602. PubMed ID: 30348770
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis.
Ortiz B; White JR; Wu WH; Chan TA
Oncotarget; 2014 Aug; 5(16):6976-82. PubMed ID: 25138050
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies of PTPRD phosphatase inhibitors identify a 7-cyclopentymethoxy illudalic acid analog candidate for development.
Henderson IM; Zeng F; Bhuiyan NH; Luo D; Martinez M; Smoake J; Bi F; Perera C; Johnson D; Prisinzano TE; Wang W; Uhl GR
Biochem Pharmacol; 2022 Jan; 195():114868. PubMed ID: 34863978
[TBL] [Abstract][Full Text] [Related]
9. Protein Tyrosine Phosphatase δ Mediates the Sema3A-Induced Cortical Basal Dendritic Arborization through the Activation of Fyn Tyrosine Kinase.
Nakamura F; Okada T; Shishikura M; Uetani N; Taniguchi M; Yagi T; Iwakura Y; Ohshima T; Goshima Y; Strittmatter SM
J Neurosci; 2017 Jul; 37(30):7125-7139. PubMed ID: 28637841
[TBL] [Abstract][Full Text] [Related]
10. Selective control of inhibitory synapse development by Slitrk3-PTPδ trans-synaptic interaction.
Takahashi H; Katayama K; Sohya K; Miyamoto H; Prasad T; Matsumoto Y; Ota M; Yasuda H; Tsumoto T; Aruga J; Craig AM
Nat Neurosci; 2012 Jan; 15(3):389-98, S1-2. PubMed ID: 22286174
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking Ptprd exhibit deficits in goal-directed behavior and female-specific impairments in sensorimotor gating.
Ho EV; Welch A; Thompson SL; Knowles JA; Dulawa SC
PLoS One; 2023; 18(5):e0277446. PubMed ID: 37205689
[TBL] [Abstract][Full Text] [Related]
12. Increasing astrogenesis in the developing hippocampus induces autistic-like behavior in mice via enhancing inhibitory synaptic transmission.
Chen J; Ma XL; Zhao H; Wang XY; Xu MX; Wang H; Yang TQ; Peng C; Liu SS; Huang M; Zhou YD; Shen Y
Glia; 2022 Jan; 70(1):106-122. PubMed ID: 34498776
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.
Mishra I; Xie WR; Bournat JC; He Y; Wang C; Silva ES; Liu H; Ku Z; Chen Y; Erokwu BO; Jia P; Zhao Z; An Z; Flask CA; He Y; Xu Y; Chopra AR
Cell Metab; 2022 Apr; 34(4):549-563.e8. PubMed ID: 35298903
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene.
Meehan M; Parthasarathi L; Moran N; Jefferies CA; Foley N; Lazzari E; Murphy D; Ryan J; Ortiz B; Fabius AW; Chan TA; Stallings RL
Mol Cancer; 2012 Feb; 11():6. PubMed ID: 22305495
[TBL] [Abstract][Full Text] [Related]
15. PTPRD silencing by DNA hypermethylation decreases insulin receptor signaling and leads to type 2 diabetes.
Chen YT; Lin WD; Liao WL; Lin YJ; Chang JG; Tsai FJ
Oncotarget; 2015 May; 6(15):12997-3005. PubMed ID: 26079428
[TBL] [Abstract][Full Text] [Related]
16. Loss of CC2D1A in Glutamatergic Neurons Results in Autistic-Like Features in Mice.
Yang CY; Hung YC; Cheng KH; Ling P; Hsu KS
Neurotherapeutics; 2021 Jul; 18(3):2021-2039. PubMed ID: 34132974
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
Veeriah S; Brennan C; Meng S; Singh B; Fagin JA; Solit DB; Paty PB; Rohle D; Vivanco I; Chmielecki J; Pao W; Ladanyi M; Gerald WL; Liau L; Cloughesy TC; Mischel PS; Sander C; Taylor B; Schultz N; Major J; Heguy A; Fang F; Mellinghoff IK; Chan TA
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9435-40. PubMed ID: 19478061
[TBL] [Abstract][Full Text] [Related]
18. Receptor protein tyrosine phosphatase sigma regulates synapse structure, function and plasticity.
Horn KE; Xu B; Gobert D; Hamam BN; Thompson KM; Wu CL; Bouchard JF; Uetani N; Racine RJ; Tremblay ML; Ruthazer ES; Chapman CA; Kennedy TE
J Neurochem; 2012 Jul; 122(1):147-61. PubMed ID: 22519304
[TBL] [Abstract][Full Text] [Related]
19. PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.
Uhl GR; Martinez MJ
Ann N Y Acad Sci; 2019 Sep; 1451(1):112-129. PubMed ID: 30648269
[TBL] [Abstract][Full Text] [Related]
20. Chondroitinase and Antidepressants Promote Plasticity by Releasing TRKB from Dephosphorylating Control of PTPσ in Parvalbumin Neurons.
Lesnikova A; Casarotto PC; Fred SM; Voipio M; Winkel F; Steinzeig A; Antila H; Umemori J; Biojone C; Castrén E
J Neurosci; 2021 Feb; 41(5):972-980. PubMed ID: 33293360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
